A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EV-077-3201-2TBS in Healthy Subjects and Type 2 Diabetic Subjects.
Phase of Trial: Phase II
Latest Information Update: 14 Jun 2013
At a glance
- Drugs SER 150 (Primary) ; Aspirin
- Indications Diabetic angiopathies; Diabetic complications; Thrombosis
- Focus Adverse reactions; Biomarker; Pharmacogenomic; Pharmacokinetics; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 03 Jun 2013 Status changed from suspended to discontinued as reported by ClinicalTrials.gov record.
- 05 Sep 2012 Status changed from recruiting to suspended, as reported by European Clinical Trials Database.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History